Novo Nordisk A/S – Share repurchase programme

Bagsværd, Denmark, 2 September 2019 – On 9 August 2019, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 (the "Safe Harbour Rules"). This programme is part of the overall share repurchase programme of up to DKK 15 billion to be executed during a 12-month period beginning 1 February 2019.

Under the programme initiated 9 August 2019, Novo Nordisk will repurchase B shares for an amount up to DKK 2.6 billion in the period from 9 August 2019 to 30 October 2019.

Since the announcement as of 26 August 2019, the following transactions have been made:

 Number of
B shares
Average
purchase price
Transaction
value, DKK
Accumulated, last announcement1,439,000 495,674,057
26 August 2019120,000351.6242,194,706
27 August 2019120,000352.4542,293,435
28 August 2019120,000352.6542,317,727
29 August 2019125,000355.5344,440,899
30 August 2019130,000351.6845,717,776
Accumulated under the programme2,054,000 712,638,600

The details for each transaction made under the share repurchase programme are published on novonordisk.com.

Transactions related to Novo Nordisk’s incentive programmes have resulted in a net transfer from Novo Nordisk of 150 B shares in the period from 26 August 2019 to 30 August 2019. The shares in these transactions were not part of the Safe Harbour repurchase programme.

With the transactions stated above, Novo Nordisk owns a total of 32,614,044 B shares of DKK 0.20, corresponding to 1.4% of the share capital, as treasury shares. The total amount of A and B shares in the company is 2,400,000,000 including treasury shares.

Novo Nordisk expects to repurchase B shares for an amount up to DKK 15 billion during a 12-month period beginning 1 February 2019. As of 30 August 2019, Novo Nordisk has since 1 February 2019 repurchased a total of 25,455,012 B shares at an average share price of DKK 327.94 per B share equal to a transaction value of DKK 8,347,592,054.

Further information

Media:  
Anne Margrethe Hauge+45 4442 3450amhg@novonordisk.com
Ken Inchausti (US)+1 609 240 9429kiau@novonordisk.com
   
Investors:  
Peter Hugreffe Ankersen+45 3075 9085phak@novonordisk.com
Valdemar Borum Svarrer+45 3079 0301jvls@novonordisk.com
Ann Søndermølle Rendbæk+45 3075 2253arnd@novonordisk.com
Kristoffer Due Berg (US)+1 609 235 2989krdb@novonordisk.com
   


Company announcement no. 51 / 2019

Attachment